Gait Rehabilitation for Knee Osteoarthritis After ACL Injury
Trial Summary
What is the purpose of this trial?
The purpose of this study is to determine the effects of real-time gait biofeedback delivered over a 6-week period on early markers of FastOA and conduct 6-week and 6-month follow-up assessments in anterior cruciate ligament reconstructed patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Real-time gait biofeedback for knee osteoarthritis after ACL injury?
Research shows that biofeedback, which provides real-time sensory feedback, can improve gait rehabilitation outcomes by helping people adjust their walking patterns. This approach has been effective in improving gait mechanics after ACL reconstruction, which may suggest potential benefits for knee osteoarthritis rehabilitation as well.12345
Is real-time gait biofeedback safe for humans?
How does real-time gait biofeedback treatment differ from other treatments for knee osteoarthritis after ACL injury?
Real-time gait biofeedback is unique because it provides immediate feedback to patients on their walking patterns, helping them adjust their gait in real-time to reduce stress on the knee joint. This approach is noninvasive and uses visual or tactile cues to guide patients in modifying their movements, which can be more effective and efficient than traditional methods that rely on verbal instructions alone.2791011
Eligibility Criteria
This trial is for individuals aged 18-35 who have had ACL reconstruction surgery between 6 and 24 months ago, completed all physical therapy, walk with less force than usual (vGRF impact peak <1.09 x body weight), and have significant knee symptoms (KOOS-QOL <72). It's not for those with a BMI ≥36, knee osteoarthritis, history of lower extremity fractures, or multiple ligament surgeries.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive real-time gait biofeedback or sham biofeedback over a 6-week period
Follow-up
Participants are monitored for safety and effectiveness after treatment with assessments at 6 weeks and 6 months
Treatment Details
Interventions
- Real-time gait biofeedback (Behavioural Intervention)
- Sham real-time gait biofeedback (Behavioural Intervention)